Fukuda opens UK base for patient monitor sales:
This article was originally published in Clinica
Fukuda Denshi, which claims to have 60% of the Japanese ECG market, has opened a UK office, initially to sell its patient monitoring devices. ECG and ultrasound sales will continue to be handled by its distributor, Cardiacare. Fukuda opened its first European office in 1993. It also has manufacturing plant in the US. In Japan, Fukuda's product line includes pacemakers and ventilators. In the year to March 31, Fukuda Denshi declared group net profits of ¥.62 billion on sales of Yen60.9 billion ($471 million) according to Reuters.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.